← Browse by Condition
Medical Condition

gastric cancer

Total Trials
43
Recruiting Now
43
Trial Phases
Phase 3, Phase 2, Phase 1
NCT04022109
Recruiting

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Enrollment
5,000 pts
Location
Brazil, Chile, Colom...
Sponsor
University of Latvia
View Trial →
NCT06102759
Recruiting

Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed

Enrollment
30 pts
Location
China
Sponsor
Tianjin Medical University Can...
View Trial →
NCT05918094 Phase 3
Recruiting

Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Enrollment
540 pts
Location
China
Sponsor
Sun Yat-sen University
View Trial →
NCT07277439 Phase 2
Recruiting

Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

Enrollment
48 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT04595929
Recruiting

Oncological Benefits of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) in Patients With T3-4 Gastric Cancer Cyt-

Enrollment
304 pts
Location
Russia
Sponsor
St. Petersburg State Pavlov Me...
View Trial →
NCT06010862 Phase 1
Recruiting

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Enrollment
36 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
View Trial →
NCT07032961
Recruiting

A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening

Enrollment
10,000 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →
NCT04613570
Recruiting

SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up

Enrollment
912 pts
Location
Portugal
Sponsor
Instituto Portugues de Oncolog...
View Trial →
NCT05349227
Recruiting

Comprehensive Outcomes for After Cancer Health

Enrollment
625 pts
Location
United States
Sponsor
Pack Health
View Trial →
NCT05804331
Recruiting

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

Enrollment
500 pts
Location
Australia
Sponsor
Western Sydney Local Health Di...
View Trial →
NCT06555471 Phase 2
Recruiting

A Single-arm, Phase II Exploratory Study of Sintilimab in Combination With Chemoradiotherapy in Elderly Patients With Locally Advanced Gastric Cancer

Enrollment
40 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT06346197 Phase 3
Recruiting

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

Enrollment
132 pts
Location
France
Sponsor
Centre Leon Berard
View Trial →
NCT06468280 Phase 2
Recruiting

Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer

Enrollment
84 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →
NCT06047379 Phase 1, Phase 2
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
View Trial →
NCT07374731
Recruiting

Identification of Biomarkers of Risk for Pre-neoplastic and Neoplastic Lesions for the Development of Gastric Cancer

Enrollment
192 pts
Location
Italy
Sponsor
Centro di Riferimento Oncologi...
View Trial →
NCT06313801 Phase 2
Recruiting

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Enrollment
106 pts
Location
Russia
Sponsor
Nizhny Novgorod Regional Clini...
View Trial →
NCT06395519 Phase 1, Phase 2
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
View Trial →
NCT06413212
Recruiting

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Enrollment
55 pts
Location
China
Sponsor
Liu Huang
View Trial →
NCT06755554 Phase 3
Recruiting

Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer

Enrollment
105 pts
Location
Ukraine
Sponsor
Ukrainian Society of Clinical ...
View Trial →
NCT05871099 Phase 3
Recruiting

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Enrollment
616 pts
Location
China
Sponsor
The Affiliated Hospital of Qin...
View Trial →
NCT05768932 Phase 1
Recruiting

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Enrollment
260 pts
Location
United States, South...
Sponsor
SillaJen, Inc.
View Trial →
NCT06988475 Phase 2, Phase 3
Recruiting

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
View Trial →
NCT07320586 Phase 2
Recruiting

Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

Enrollment
40 pts
Location
China
Sponsor
Shandong Tumor Hospital
View Trial →
NCT06791083 Phase 2
Recruiting

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Enrollment
40 pts
Location
China
Sponsor
First Affiliated Hospital of F...
View Trial →
NCT06508307 Phase 1
Recruiting

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

Enrollment
21 pts
Location
China
Sponsor
GONGCHU Biotechnology Co., Ltd
View Trial →
NCT07139366 Phase 4
Recruiting

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Enrollment
1,248 pts
Location
China
Sponsor
Yongquan Shi
View Trial →
NCT05894824 Phase 1, Phase 2
Recruiting

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Enrollment
58 pts
Location
South Korea
Sponsor
Yonsei University
View Trial →
NCT06873659 Phase 1
Recruiting

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Enrollment
96 pts
Location
China
Sponsor
Qurgen Inc.
View Trial →
NCT04342910 Phase 3
Recruiting

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Enrollment
550 pts
Location
China
Sponsor
Jiangsu HengRui Medicine Co., ...
View Trial →
NCT06776770 Phase 1, Phase 2
Recruiting

A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer

Enrollment
52 pts
Location
China
Sponsor
Cancer Hospital Chinese Academ...
View Trial →
NCT03787056
Recruiting

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT06580002 Phase 2
Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Enrollment
51 pts
Location
United States
Sponsor
University of California, Irvi...
View Trial →
NCT04282044 Phase 1
Recruiting

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Enrollment
60 pts
Location
United States
Sponsor
BioEclipse Therapeutics
View Trial →
NCT05472857 Phase 1
Recruiting

Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression

Enrollment
30 pts
Location
China
Sponsor
Suzhou Immunofoco Biotechnolog...
View Trial →
NCT06202105
Recruiting

Comparison of Laparoscopic and Open Total Gastrectomy for Locally Advanced Gastric Cancer

Enrollment
210 pts
Location
Vietnam
Sponsor
University Medical Center Ho C...
View Trial →
NCT07142122
Recruiting

Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial

Enrollment
76 pts
Location
China
Sponsor
Fujian Cancer Hospital
View Trial →
NCT06608381 Phase 3
Recruiting

Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10)

Enrollment
440 pts
Location
South Korea
Sponsor
Gangnam Severance Hospital
View Trial →
NCT06035250
Recruiting

AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

Enrollment
200 pts
Location
China, Italy
Sponsor
Chinese Academy of Sciences
View Trial →
NCT05514769
Recruiting

Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer

Enrollment
60 pts
Location
China
Sponsor
Nanchong Central Hospital
View Trial →
NCT07026240
Recruiting

Post-operative Monitoring of Gastric Cancer

Enrollment
258 pts
Location
China
Sponsor
Suzhou Huhu Health & Technolog...
View Trial →
NCT06405113 Phase 2
Recruiting

FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer

Enrollment
198 pts
Location
China
Sponsor
Changzhou No.2 People's Hospit...
View Trial →
NCT06791148 Phase 2
Recruiting

Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer

Enrollment
45 pts
Location
China
Sponsor
The Affiliated Nanjing Drum To...
View Trial →
NCT03716089
Recruiting

Comparison of Tumor Efficacy Safety in Laparoscopic Resection of Gastrointestinal Stromal Tumors Between Favorable and Unfavorable Site

Enrollment
250 pts
Location
China
Sponsor
Fujian Medical University
View Trial →